G01N 2800/2892
Myotonic dystrophy
G01N2800/2892 (Myotonic dystrophy) appears on 7 US grants and 9 published applications in this corpus.
Search patents in G01N- Granted patents
- 7
- Published applications
- 9
- Assignees
- 8
- Inventors
- 22
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- RAN proteins as biomarkers in CAG/CTG expansion disorders26 May 2026US 12,638,457 B2University of Florida Research Foundation, Inc.
- CDK12 inhibitors and their uses7 Mar 2023US 11,596,631 B2The University of Nottingham
- Therapeutic and diagnostic methods involving biglycan and utrophin1 May 2018US 9,958,458 B2Brown University
- Synthetic analogues of neural regeneration peptides16 May 2017US 9,650,418 B2Curonz Holdings Company Limited
- Synthetic analogues of neural regeneration peptides26 May 2015US 9,040,485 B2Curonz Holdings Company Limited
- Ran proteins as biomarkers in cag/ctg expansion disorders29 Feb 2024US 2024/0069039 A1University of Florida Research Foundation, Inc.
- Inhibitors and their uses7 Feb 2019US 2019/0038625 A1The University of Nottingham
- Synthetic analogues of neural regeneration peptides3 Aug 2017US 2017/0218023 A1Curonz Holdings Company Limited
- Synthetic analogues of neural regeneration peptides29 Oct 2015US 2015/0307553 A1Curonz Holdings Company Limited
- Therapeutic and diagnostic methods involving biglycan and utrophin6 Feb 2014US 2014/0038906 A1Brown University
Most cited
By later US patents
- Method for treating myolytic disease and method for screening antimyolytic agent5US 7,238,718 B2Osaka Bioscience Institute · 2007
- CDK12 inhibitors and their uses2US 11,596,631 B2The University of Nottingham · 2023
- Synthetic analogues of neural regeneration peptides2US 8,309,684 B2Curonz Holdings Company Limited · 2012
- Synthetic analogues of neural regeneration peptides1US 9,040,485 B2Curonz Holdings Company Limited · 2015